Login / Signup

Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature.

Lennart von FritschNikolas von BubnoffKlaus WeberJutta KirfelCleopatra SchreiberTobias KeckUlrich Wellner
Published in: Genes, chromosomes & cancer (2024)
Studies suggest that up to one-fourth of PACCs carry a BRAF mutation and might therefore be susceptible to a BRAF-/MEK-inhibitor therapy. This offers a new therapeutic pathway to treat this rare but malignant neoplasm.
Keyphrases